Abstract:Introduction: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the US, and more than 1.2 million patients are diagnosed with CRC worldwide annually, with 5 year survival rates of ~64%.Accumulating evidence indicates that epigenetic modifications play a critical role in progression of CRC.In particular, over the last decade, dysregulated expression of microRNAs (miRNAs) has been established as a hallmark of cancer.Exportin-5 (XPO5), a member of the karyopherin family, is a key protein responsible for the transportation of precursor miRNAs from the nucleus to the cytoplasm.While XPO5 is perhaps the most critical regulator during miRNA biogenesis, the clinical usefulness of XPO5 expression alteration as a potential biomarker in CRC remains unexplored.Aims: We aimed to investigate the clinical significance of XPO5 expression in CRC, and determine its functional role in CRC.Materials and Methods: The expression level of XPO5 was systematically assessed in three independent microarray-based datasets.The relationship between XPO5 expression and clinicopathological features was subsequently validated in two independent CRC patient cohorts.A functional characterization of the role of XPO5 in CRC was examined by targeted gene silencing in a panel of cell lines and xenograft animal models.Finally, we correlated XPO5 expression and alterations in miRNA signatures in CRC.Results: Three independent microarray dataset analyses in the discovery step revealed that XPO5 was consistently among the top 1% overexpressed genes in CRCs compared with normal tissues.High-XPO5 expression associated with worse clinicopathological features including depth of invasion and distant metastasis in two independent patient cohorts.Moreover, CRC patients with high-XPO5 expression demonstrated significantly worse overall survival.SiRNA knockdown of XPO5 in CRC cell lines resulted in reduced cellular proliferation and invasion, and the induction of G1/S cell cycle arrest.Expression levels of key oncogenic miRNAs were downregulated following inhibition of XPO5 in CRC cells, which was consistent with our observation that the expression of oncogenic miRNA clusters correlates positively with XPO5 expression in CRC tissues.Finally, we validated our in-vitro results by demonstrating that silencing of XPO5 resulted in the attenuation of tumor growth in a xenograft animal model. Conclusion:Our results demonstrate that XPO5 acts as an oncogene in CRC through regulation of specific miRNA clusters.The association between high-XPO5 expression and poor survival in CRC patients highlights its significance as a potential prognostic marker and a therapeutic target in CRC.

Downregulation and Tumor-Suppressive Role of XPO5 in Hepatocellular Carcinoma

Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest

Knockdown of Eukaryotic Translation Initiation Factor 5A2 Enhances the Therapeutic Efficiency of Doxorubicin in Hepatocellular Carcinoma Cells by Triggering Lethal Autophagy

Targeting XPO6 Inhibits Prostate Cancer Progression and Enhances the Suppressive Efficacy of Docetaxel

Prognostic significance of exportin-5 in hepatocellular carcinoma

Higher expression of cell division cycle-associated protein 5 predicts poorer survival outcomes in hepatocellular carcinoma

Effects of Knockdown of XPO5 by siRNA on the Biological Behavior of Head and Neck Cancer Cells

Hepatitis B Virus X Protein Promotes Tumor Glycolysis by Downregulating Lncrna OIP5-AS1/HKDC1 in HCC

The Role of XBP1s in the Metastasis and Prognosis of Hepatocellular Carcinoma

Eg5 As a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma

Exportin-T promotes tumor proliferation and invasion in hepatocellular carcinoma

Regulatory Factor X5 Promotes Hepatocellular Carcinoma Progression by Transactivating Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta and Suppressing Apoptosis

NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression

Clinicopathological and Prognostic Significance of XPO1 in Solid Tumors: Meta-Analysis and TCGA Analysis.

CMTM5 is Downregulated and Suppresses Tumour Growth in Hepatocellular Carcinoma Through Regulating PI3K-AKT Signalling

Tu2063 Germline Mutations in Two Hereditary Early On-Set Gastric Cancer Families

Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma

CXXC5 suppresses hepatocellular carcinoma by promoting TGF-&bgr;-induced cell cycle arrest and apoptosis

Transcriptomic Analyses of Chemokines Reveal That Down-Regulation of XCR1 is Associated with Advanced Hepatocellular Carcinoma

CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.

Overexpressed Tumor Suppressor Exosomal miR-15a-5p in Cancer Cells Inhibits PD1 Expression in CD8+T Cells and Suppresses the Hepatocellular Carcinoma Progression